121 related articles for article (PubMed ID: 27833608)
1. Corrigendum: Bacteriophage Procurement for Therapeutic Purposes.
Weber-Dąbrowska B; Jończyk-Matysiak E; Żaczek M; Łobocka MB; Łusiak-Szelachowska M; Górski A
Front Microbiol; 2016; 7():1813. PubMed ID: 27833608
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage Procurement for Therapeutic Purposes.
Weber-Dąbrowska B; Jończyk-Matysiak E; Żaczek M; Łobocka M; Łusiak-Szelachowska M; Górski A
Front Microbiol; 2016; 7():1177. PubMed ID: 27570518
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
Kakasis A; Panitsa G
Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Exploring the Secretomes of Microbes and Microbial Communities Using Filamentous Phage Display.
Gagic D; Ciric M; Wen WX; Ng F; Rakonjac J
Front Microbiol; 2016; 7():927. PubMed ID: 27379057
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Identification and Characterization of Dpo42, a Novel Depolymerase Derived from the
Guo Z; Huang J; Yan G; Lei L; Wang S; Yu L; Zhou L; Gao A; Feng X; Han W; Gu J; Yang J
Front Microbiol; 2017; 8():2103. PubMed ID: 29097995
[TBL] [Abstract][Full Text] [Related]
7. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
Zhang G; Zhao Y; Paramasivan S; Richter K; Morales S; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2018 Mar; 8(3):406-414. PubMed ID: 29240296
[TBL] [Abstract][Full Text] [Related]
11. Study of therapeutic potential of the experimental pseudomonas bacteriophage preparation.
Dzuliashvili M; Gabitashvili K; Golidjashvili A; Hoyle N; Gachechiladze K
Georgian Med News; 2007 Jun; (147):81-8. PubMed ID: 17660609
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
[TBL] [Abstract][Full Text] [Related]
13. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
14. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
[TBL] [Abstract][Full Text] [Related]
15. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
16. Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.
Burrowes BH; Molineux IJ; Fralick JA
Viruses; 2019 Mar; 11(3):. PubMed ID: 30862096
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2005 and 2012: Epidemiology and Profiles of Resistance.
Daoud Z; Salem Sokhn E; Masri K; Cheaito K; Haidar-Ahmad N; Matar GM; Doron S
Front Med (Lausanne); 2015; 2():66. PubMed ID: 26442268
[TBL] [Abstract][Full Text] [Related]
18. Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by
Nikkhahi F; Soltan Dallal MM; Alimohammadi M; Rahimi Foroushani A; Rajabi Z; Fardsanei F; Imeni SM; Torabi Bonab P
Gastroenterol Hepatol Bed Bench; 2017; 10(2):131-136. PubMed ID: 28702137
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Vaccines Against Antimicrobial Resistance.
Rosini R; Nicchi S; Pizza M; Rappuoli R
Front Immunol; 2020; 11():1578. PubMed ID: 32849536
[TBL] [Abstract][Full Text] [Related]
20. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
Hesse S; Adhya S
Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
